Detalhe da pesquisa
1.
SOX9 is a target of miR-134-3p and miR-224-3p in breast cancer cell lines.
Mol Cell Biochem
; 478(2): 305-315, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-35779228
2.
Reprogramming of macrophages employing gene regulatory and metabolic network models.
PLoS Comput Biol
; 16(2): e1007657, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32097424
3.
Retraction Note to: cGMP-phosphodiesterase 6, transducin and Wnt5a/Frizzled-2-signaling control cGMP and Ca2+ homeostasis in melanoma cells.
Cell Mol Life Sci
; 77(5): 963, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31919573
4.
Cost of decentralized CAR T-cell production in an academic nonprofit setting.
Int J Cancer
; 147(12): 3438-3445, 2020 12 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32535920
5.
A vaccine targeting mutant IDH1 induces antitumour immunity.
Nature
; 512(7514): 324-7, 2014 Aug 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-25043048
6.
A universal anti-cancer vaccine: Chimeric invariant chain potentiates the inhibition of melanoma progression and the improvement of survival.
Int J Cancer
; 144(4): 909-921, 2019 02 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30106470
7.
Patterns of antibody responses to nonviral cancer antigens in head and neck squamous cell carcinoma patients differ by human papillomavirus status.
Int J Cancer
; 145(12): 3436-3444, 2019 12 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31407331
8.
A transplantable tumor model allowing investigation of NY-BR-1-specific T cell responses in HLA-DRB1*0401 transgenic mice.
BMC Cancer
; 19(1): 914, 2019 Sep 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-31519152
9.
Clinical translation and regulatory aspects of CAR/TCR-based adoptive cell therapies-the German Cancer Consortium approach.
Cancer Immunol Immunother
; 67(4): 513-523, 2018 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-29380009
10.
Reply to: Comments on "Cost of decentralized CAR T cell production in an academic non-profit setting".
Int J Cancer
; 148(2): 516-517, 2021 01 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32798336
11.
Identification of NY-BR-1-specific CD4(+) T cell epitopes using HLA-transgenic mice.
Int J Cancer
; 136(11): 2588-97, 2015 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25387692
12.
Prognostic significance of spontaneous antibody responses against tumor-associated antigens in malignant melanoma patients.
Int J Cancer
; 136(1): 138-51, 2015 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-24839182
13.
T cell responses in early-stage melanoma patients occur frequently and are not associated with humoral response.
Cancer Immunol Immunother
; 64(11): 1369-81, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26160687
14.
Estimating the activity of transcription factors by the effect on their target genes.
Bioinformatics
; 30(17): i401-7, 2014 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25161226
15.
miR-137 inhibits proliferation of melanoma cells by targeting PAK2.
Exp Dermatol
; 24(12): 947-52, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26186482
16.
LRAT overexpression diminishes intracellular levels of biologically active retinoids and reduces retinoid antitumor efficacy in the murine melanoma B16F10 cell line.
Skin Pharmacol Physiol
; 28(4): 205-212, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25721651
17.
Survivin blockade sensitizes rhabdomyosarcoma cells for lysis by fetal acetylcholine receptor-redirected T cells.
Am J Pathol
; 182(6): 2121-31, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23562272
18.
Knockdown of lecithin retinol acyltransferase increases all-trans retinoic acid levels and restores retinoid sensitivity in malignant melanoma cells.
Exp Dermatol
; 23(11): 832-7, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25236354
19.
Lecithin retinol acyltransferase as a potential prognostic marker for malignant melanoma.
Exp Dermatol
; 22(11): 757-9, 2013 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-24433184
20.
Novel microRNAs modulating ecto-5'-nucleotidase expression.
Front Immunol
; 14: 1199374, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37409119